FeesSafety
Pluang+

Gix Internet to delist from Tel Aviv Stock Exchange, focus trading exclusively on Nasdaq

Company Fundamentals
23 Oct 2026
GlobeNewsWire
View Source
Neutral
Gix Internet to delist from Tel Aviv Stock Exchange, focus trading exclusively on Nasdaq

Gix Internet Ltd. announced it will voluntarily delist its ordinary shares from the Tel Aviv Stock Exchange by January 27, 2027, to focus exclusively on trading on the Nasdaq in the U.S. This move aims to enhance liquidity on Nasdaq and reduce administrative costs associated with dual listing. The company will continue to comply with U.S. SEC regulations and maintain its Nasdaq listing under the symbol GIXI. Shareholders can trade shares on the Tel Aviv exchange until January 25, 2027, after which trading will be solely on Nasdaq.

Gix Internet's move to trade exclusively on Nasdaq provides context for technology sector activity on Pluang. As of Oct 23, 2026 18:03 WIB, among 150 priced US technology stocks, 49 rose and 92 fell. Notable movers include VNET at USD 3.92 with a 3.43% gain and a 60% buy order activity, FIRY at USD 11.33 down 2.50%, and CLS at USD 273.60 up 1.71% with 100% buy orders.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
17 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App